The risk of developing colorectal cancer can be reduced by more than 60% by taking two aspirins a day, a British study has revealed.
A trial of 1,000 patients with a genetic condition that predisposes them to developing the disease found that taking aspirin over a two year period slashed their chances of actually contracting the illness by more than half.
The participants in the poll were split into two – one half took aspirin and the other half took a placebo.
Tim Bishop, one of the authors of the study and a professor of epidemiology at Leeds University in England, said: “This is one more piece of evidence that there are some very positive effects of aspirin, and it should be considered very seriously for people who are at risk of colorectal cancer.”
John Burn, lead author of the study, said: “We have clear proof that aspirin prevents cancer in people at high genetic risk. We now have new questions to answer: Will low dose be as effective as two aspirins? Should all people at increased risk take aspirin?”
Have a senior living related news story or product release? Send us a message from the 'Contact Us' page.